文献速递炎症性肠病肝病

炎症性肠病合并慢性肝病孕妇的母婴结局

Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease.
PubMed 文献 · Aliment Pharmacol Ther · 2025-10-23

基于美国2016-2022年全国住院样本的回顾性队列研究,分析21304600例分娩中IBD合并CLD(680例)与单纯IBD或CLD的母婴结局。结果显示IBD+CLD较单纯IBD或CLD有更高的妊娠剧吐、早产、妊娠期高血压疾病、剖宫产、围产期情绪障碍等风险,提示两种疾病共存带来叠加风险,需多学科管理。

要点

  • IBD合并CLD孕妇的妊娠剧吐、早产、HDP、剖宫产风险高于单纯IBD或CLD。
  • IBD合并CLD者胎儿死亡风险高于单纯CLD,严重孕产妇发病和产后出血风险高于单纯IBD。
  • 建议对孕妇进行基于风险的慢性肝病筛查并开展多学科管理。

核心结论

  • IBD与CLD共存对母婴结局的风险高于任一疾病单独存在。

研究设计与样本

  • 回顾性队列研究,使用2016-2022年美国全国住院样本中≥18岁女性的分娩住院记录。
  • 分娩按ICD-10编码分为IBD+CLD、IBD、CLD或两者均无,共纳入21304600例分娩。

主要发现

  • 在21304600例分娩中,CLD为178025例,IBD为47555例,IBD+CLD为680例。
  • IBD+CLD中慢性病毒性肝炎是最常见CLD,自身免疫性肝病占肝硬化的一半。
  • IBD+CLD对比IBD或CLD的妊娠剧吐OR为2.64 vs. 3.68,早产为2.50 vs. 1.69,HDP为1.96 vs. 1.60,剖宫产为1.92 vs. 1.61,围产期情绪障碍为1.75 vs. 1.45,胎膜早破为1.35 vs. 1.39。
  • IBD+CLD对比CLD的胎儿死亡OR为1.97,对比IBD的严重孕产妇发病OR为1.76、产后出血OR为1.56,所有p≤0.05。

临床怎么用

  • 对IBD合并CLD的孕妇应加强母婴风险监测与多学科协作管理。
  • 考虑对孕妇进行基于风险的慢性肝病筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel disease (IBD) and chronic liver disease (CLD) are each associated with adverse pregnancy outcomes, but the impact of coexisting IBD and CLD on pregnancy remains understudied. AIMS: To assess CLD prevalence among pregnant women with and without IBD and evaluate maternal and perinatal outcomes. METHODS: We conducted a retrospective cohort study of delivery hospitalisations among women ≥ 18 years using the 2016-2022 United States National Inpatient Sample. Deliveries were categorised as IBD + CLD, IBD, CLD or neither using ICD-10 codes. Weighted multivariable regression adjusted for demographics, comorbidities and cirrhosis. RESULTS: Among 21,304,600 deliveries, 178,025 had CLD, 47,555 had IBD and 680 had IBD + CLD. Chronic viral hepatitis was the most common CLD, while autoimmune liver disease accounted for half of cirrhosis in IBD + CLD. Compared to IBD or CLD, IBD + CLD had higher odds of hyperemesis gravidarum (2.64 vs. 3.68), preterm birth (2.50 vs. 1.69), hypertensive disorders of pregnancy (HDP) (1.96 vs. 1.60), caesarean delivery (1.92 vs. 1.61), perinatal mood disorder (1.75 vs. 1.45) and premature rupture of membranes (1.35 vs. 1.39). IBD + CLD had greater odds of fetal death (1.97) versus CLD and of severe maternal morbidity (1.76) and postpartum haemorrhage (1.56) versus IBD. All p ≤ 0.05. CONCLUSIONS: Coexisting IBD and CLD confer compounded maternal and perinatal risks beyond either condition alone. Multidisciplinary care and risk-based screening for underlying CLD in pregnant women are warranted.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Lee JD, Papamichael K, Grinspan LT, et al. Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease. Aliment Pharmacol Ther. 2025. PMID: 41128005. doi:10.1111/apt.70425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。